| (210) | Number of the EPO application | 17835968 |
| (220) | Filing date of the EPO application | 2017.12.04 |
| (80) | EPO patent specification publication (B) | EPB nr. 24/2023, 2023.06.14 |
| (110) | EPO patent number | 3548011 |
| (21) | Number of the application | e 2019 1147 |
| (71) | Name(s) of applicant(s), code of the country | Regulus Therapeutics Inc., US;
The Board of Regents of the University of
Texas System, US; |
| (72) | Name(s) of inventor(s), code of the country | ALLERSON Charles R., US;
PATEL Vishal D., US;
CHAU B. Nelson, US;
ANDROSAVICH John R., US; |
| (73) | Name(s) of owner(s), code of the country | Regulus Therapeutics Inc., US;
The Board of Regents of the University of
Texas System, US; |
| (54) | Title of the invention | METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/7088 (2006.01.01); A61K 31/7125 (2006.01.01); A61K 31/00 (2006.01.01); A61P 13/12 (2006.01.01); C12N 15/113 (2010.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.11.30 |
| (30) | Priority | 201662430164 P, 2016.12.05, US |
| (86) | International application | PCT/US2017/064432, 2017.12.04 |
| (87) | International publication | WO 2018/106568, 2018.06.14 |